Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2023. Start Trial.
Date Value
October 30, 2026 1.150
October 29, 2026 1.154
October 28, 2026 1.129
October 27, 2026 1.133
October 26, 2026 1.110
October 23, 2026 1.114
October 22, 2026 1.153
October 21, 2026 1.157
October 20, 2026 1.203
October 19, 2026 1.157
October 16, 2026 1.108
October 15, 2026 1.167
October 14, 2026 1.150
October 13, 2026 1.173
October 12, 2026 1.257
October 09, 2026 1.343
October 08, 2026 1.350
October 07, 2026 1.403
October 06, 2026 1.444
October 05, 2026 1.451
October 02, 2026 1.455
October 01, 2026 1.524
September 30, 2026 1.644
September 29, 2026 1.719
September 28, 2026 1.844
Date Value
September 25, 2026 1.889
September 24, 2026 1.894
September 23, 2026 1.890
September 22, 2026 1.941
September 21, 2026 1.936
September 18, 2026 1.840
September 17, 2026 1.846
September 16, 2026 1.867
September 15, 2026 2.048
September 14, 2026 2.021
September 11, 2026 2.033
September 10, 2026 2.080
September 09, 2026 2.168
September 08, 2026 2.123
September 04, 2026 2.489
September 03, 2026 2.489
September 02, 2026 2.513
September 01, 2026 2.478
August 31, 2026 2.414
August 28, 2026 2.491
August 27, 2026 2.588
August 26, 2026 2.595
August 25, 2026 2.625
August 24, 2026 2.577
August 21, 2026 2.581

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly & Co. 33.13
Novo Nordisk A/S 5.225
Pfizer Inc. 2.042
Viking Therapeutics, Inc. 5.910
Liquidia Corp. 20.58

Price to Book Value Related Metrics

Price 21.87
Earnings Yield -14.08%
Market Cap 1.558B